Presentations Media coverage

Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy.

Half of all cancer patients fail chemotherapy. This resistance increases mortality and represents a major burden for the health care system.

Presentation

Scandion Oncology Capital Markets Day

Watch the presentations from Scandion Oncology’s Capital Markets Day on September 8, 2021.
Watch
Presentation

Audiocast, CORIST part 1 study

Watch Scandion Oncology’s presentation of the interim results from the CORIST Phase II study, which were presented on June 24, 2021.
Watch
Presentation

Q1 Interim Report

Hear Scandion Oncology's audiocast from publishing our Interim Report for Q1 2021
Hear
Presentation

Nordnet Live

Watch Scandion Oncology's presentation from Nordnet Live on May 11.
Watch
Presentation

Watch CEO Bo Rode Hansen present at Økonomisk Ugebrev

Scandion Oncology´s President and CEO, Bo Rode Hansen gave a live virtual presentation followed by a Q&A session on April 21 at Økonomisk Ugebrev’...
Watch
Media coverage

Invest Talks

Read the interview (in Swedish) with CEO Bo Rode Hansen featured in today’s “Invest Talks - Sektoranalys Health Care in Dagens Industri” here.
Read
Media coverage

Year-end 2020 webcast (video)

Thank you to all attendees who joined our live Year-end 2020 webcast & Q&A. See the webcast.
See the webcast
Presentation

Year-end 2020 webcast (pdf)

Thank you to all attendees who joined our live Year-end 2020 webcast & Q&A. Read the investor presentation.
See presentation (pdf)
Media coverage

BioStock: Scandion Oncology tackles antioestrogen resistance

Scandion Oncology is currently evaluating its lead candidate SCO-101 in two clinical trials, one with drug resistant metastatic colorectal cancer and ...
Read more
Media coverage

Onkologisk Tidsskrift

Dansk lægemiddel ser ud til at bekæmpe resistens på tværs af kræftsygdomme
Read more
Media coverage

Hopp för framtidens cancerbehandlingar

10 miljoner människor dör om året i cancer. Huvudorsaken till 90 procent av dödsfallen är att cancerceller kan utveckla resistens mot cellgiftsbe...
Read more
Media coverage

indblik+

Ny direktør: Scandion Oncology skal være førende inden for kemoterapiresistens
Read more
Presentation

San Antonio Breast Cancer Symposium

Jan Stenvang presented a poster.
See poster
Presentation

MVA Oncology Network

Jan Stenvang presented at MVA Oncology Network Meeting.
Watch
Presentation

Ophelia Invest Talks

Bliv klogere på biotek branchen og særligt på biotekselskabet Scandion Oncology.
Listen (podcast)
Presentation

BioStock Live med Scandion Oncology

BioStock Studio: Scandion Oncology outlines vision to fight cancer drug resistance
Watch
Presentation

Aktieportföljen Live November 24, 2020

Presentation from Aktieportföljen Live November 24, 2020
Watch
Presentation

Selskaberne live: Scandion Oncology

Kræft-relaterede dødsfald skyldes i 90% af tilfældene resistens over for kemoterapi. Det arbejder Scandion Oncology for at ændre på. Selskabet er...
Watch
Presentation

Highlights from Q3, 2020

Presentation from webcast, presenting highlights from Q3, 2020
Download
Presentation

Scandion Oncology Interview

BioStock interviews CEO Bo Rode Hansen and CSO Nils Brünner at Scandion Oncology.
Watch
Media coverage

Genevant Sciences CEO joins board at Danish oncology firm

Biotech company Scandion Oncology expands its board of directors, adding Bo Rode Hansen, who left an executive position at Roche in 2018 to become chi...
Read more
Media coverage

CEO Nils Brünner has been appointed as member of Lund University’s Faculty of Medicine Board

Scandion Oncology’s CEO appointed as member of Lund University’s Faculty of Medicine Board
Download
Presentation

Investor meeting

I samarbete med Sedermera så presenterar vd Nils Brünner Scandion Oncology i Köpenhamn 25/6.
Watch
Presentation

Investor meeting (Financial Stockholm)

Mötesplats för aktie och fondintresserade. Financial Stockholm arrangeras flertal gånger i Stockholm city. Här möts finansproffs och småsparare.
Watch
Presentation

BioStock Live investerarträff in Stockholm

Scandion Oncologys vid Nils Brünner presenterar bolaget i samband med BioStock Live 13 juni 2019
Watch
Presentation

VD-intervju (BioStock Live investerarträff)

BioStocks analytiker Linus Flink Elmfors intervjuar Nils Brünner, vd Scandion Oncology.
Watch
Presentation

Småbolagsdagen 2019 in Stockholm

Nils Brünner presenterar bolaget.
Watch
Presentation

Scandion Oncology från Öresundsdagen

VD Nils Brünner presenterar bolaget.
Watch
Presentation

Sedermeradagen Köpenhamn 2019

Watch
Presentation

Year-end report

Interview with Nils
Watch
Presentation

Stora Aktiedagen

Stora Aktiedagen Stockholm 2018. VD Nils Brunner presenterar bolaget.
Watch
Presentation

Spotlight

CEO, Nils Brünner says “Scandion Oncology is extremely proud to be listed on Spotlight Stock Market and had it first day of trading shares on Nov. ...
Watch
Presentation

Presentation – Scandion Oncology

Scandion Oncology was formed as a spin-out company from the University of Copenhagen and the research and development company Saniona AB in 2017 for t...
Watch
Presentation

Market analysis

Long range strategic patient and commercial forecast. The value SCO-101 offer to patients and healthcare providers targeting breat- and colorectal can...
Download
Presentation

Company Presentation

Presentation of Scandion Oncology
Watch
Presentation

Nordnet webinar

Nils Brünner, CEO at Scandion Oncology, presented at a webinar hosted by Nordnet on October 15th, 2018. The presentation explained the background of ...
Watch
Presentation

Scandion Oncology – Sedermeradagen Göteborg 2018

Bolaget Scandion Oncology presenterar på Sedermeradagen i Göteborg den 11 oktober 2018.
Watch
Media coverage

Interview – Investerarträff Copenhagen, October 4, 2018

I en intervju med Finwire.tv berättar CEO Nils Brünner om bolaget, marknaden och planerna framåt.
Watch
Presentation

Presentation – Investerarträff Copenhagen, October 4, 2018

Scandion Oncology med vd Nils Brünner presenterar live i Köpenhamn torsdagen den 4. oktober 2018.
Watch
Presentation

Scandion Oncology presents at Sedermeradagen Malmö 2018

Scandion Oncology på Sedermeradagen i Malmö 2018
Watch